Author:
Kluetz Paul G,O'Connor Daniel J,Soltys Katherine
Reference42 articles.
1. Toward patient-centered drug development in oncology;Basch;N Engl J Med,2013
2. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labelling claims,2009
3. Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man. The use of patient-reported outcome (PRO) measures in oncology studies,2016
4. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE);Basch;J Natl Cancer Inst,2014
5. Validity and reliability of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE);Dueck;JAMA Oncol,2015